Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine

https://doi.org/10.1016/0014-2999(77)90202-3Get rights and content

Abstract

The interaction of sympathomimetic amines with the transport of 3H-noradrenaline (3H-NE), 3H-dopamine (3H-DA) and 3H-5-hydroxytriptamine (3H-5-HT) were investigated in rat hypothalamic (3H-NE) and striatal (3H-DA and 3H-5-HT) synaptosomes. Modifications in the phenylethylamine structure led to changes in activity towards biogenic amine uptake and release: (a) the introduction of a β-OH group led to compounds less active in inhibiting uptake and stimulating release of 3H-NE, 3H-DA and 3H-5-HT, with the exception of 3H-NE release which was stimulated more by unlabeled 1-NE than by DA; (b) the introduction of phenolic -OH groups always led to compounds which were stronger uptake inhibitors and releasers of the three biogenic amines; (c) the α-methylation increased the potency towards uptake inhibition and release stimulation, with the exception of 3H-NE release: in fact, the releasing activity of phenylethylamine was suppressed by α-methylation; (d) the introduction of a -Cl group in the para position selectively potentiated the effects on 3H-5-HT uptake and release and generally depressed those on catecholamine transport.

References (33)

  • G.B. Baker et al.

    Interaction of β-phenylethylamine with dopamine and noradrenaline in the central nervous system of the rat

    J. Pharm. Pharmacol.

    (1976)
  • R.J. Baldessarini

    Compounds antagonistic to norepinephrine retention by rat brain homogenates

    Biochem. Pharmacol.

    (1971)
  • R.J. Baldessarini et al.

    The uptake and subcellular distribution of aromatic amines in the brain of the rat

    J. Neurochem.

    (1971)
  • A.S.V. Burgen et al.

    The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart

    Brit. J. Pharmacol. Chemotherap.

    (1965)
  • D.A. Durden et al.

    Identification and distribution of β-phenylethylamine in the rat

    Can. J. Biochem.

    (1973)
  • E.G. Gray et al.

    The isolation of nerve endings from brain: an electron microscope study of cell fragments derived by homogenization and centrifugation

    J. Anat. (London)

    (1962)
  • Cited by (198)

    • Modafinil, an atypical CNS stimulant?

      2024, Advances in Pharmacology
    • Pharmacogenomics of drugs of abuse

      2019, Critical Issues in Alcohol and Drugs of Abuse Testing
    • The role of human dopamine transporter in NeuroAIDS

      2018, Pharmacology and Therapeutics
    • SadA-Expressing Staphylococci in the Human Gut Show Increased Cell Adherence and Internalization

      2018, Cell Reports
      Citation Excerpt :

      However, these reactions may also occur by the gut microflora. Not only the classical neurotransmitters, but TAs as well can exert pronounced pharmacological effects in many species; they can affect uptake or release of catecholamines or serotonin activity at nerve endings (Raiteri et al., 1977), and they might also act as neuromodulators through direct actions on receptors for catecholamines or serotonin (Jones, 1982; Paterson and Boulton, 1988). TAs are attracting attention as neurotransmitters because they are believed to play a role in human disorders (Branchek and Blackburn, 2003; Martinucci et al., 2015).

    • Methods of Trace Amine Analysis in Mammalian Brain

      2016, Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
    View all citing articles on Scopus
    View full text